Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. (Q48283887)

10 February 2018

title

Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. (English)

1 reference

10 February 2018

0 references

W Foulon

1

1 reference

10 February 2018

I Villena

2

1 reference

10 February 2018

B Stray-Pedersen

3

1 reference

10 February 2018

A Decoster

4

1 reference

10 February 2018

M Lappalainen

5

1 reference

10 February 2018

J M Pinon

6

1 reference

10 February 2018

P A Jenum

7

1 reference

10 February 2018

K Hedman

8

1 reference

10 February 2018

A Naessens

9

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

10 February 2018

American Journal of Obstetrics and Gynecology

published in

1 reference

10 February 2018

volume

180

1 reference

10 February 2018

page(s)

410-415

1 reference

10 February 2018

issue

2 Pt 1

1 reference

10 February 2018

Results of 20-year follow-up of congenital toxoplasmosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

Congenital toxoplasmosis. A prospective study of 378 pregnancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

Toxoplasmosis in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

Evaluation of the possibilities for preventing congenital toxoplasmosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

Prenatal diagnosis of congenital toxoplasmosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. The Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970224-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9378(99)70224-3

1 reference

10 February 2018

PubMed ID

9988811

1 reference

10 February 2018